Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rodger Novak currently holds 573,007 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rodger Novak has been a net seller of CRSP stock. They have purchased $0 and sold $72.2M worth of shares.
Rodger Novak's most recent insider trade was on Jun 30, 2021, when they sold 25,000 shares at $165.00 per share.
Rodger Novak serves as Executive at CRISPR Therapeutics AG (CRSP). They have executed 84 insider transactions totaling $72.2M over their tenure at the company.
Rodger Novak holds the position of Executive at CRISPR Therapeutics AG, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Rodger Novak has shown a selling trading pattern, with $0 in total purchases and $72.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Rodger Novak was on Nov 30, 2020, when they sold $6.3M worth of CRSP shares. This transaction involved 50,000 shares at $125.00 per share.
Rodger Novak currently owns 573,007 shares of CRISPR Therapeutics AG (CRSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rodger Novak's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rodger Novak has 84 Form 4 filings on record as an insider at CRISPR Therapeutics AG.
Set alerts for Rodger Novak and 40,000+ other insiders.